PEAK ROCK CAPITAL AFFILIATE COMPLETES ACQUISITION OF ASEMBIA

An affiliate of Peak Rock Capital has successfully acquired Asembia LLC, a prominent provider of technology-enabled commercialization solutions for the specialty pharmaceutical industry. The deal, announced on July 2, 2026, involves an undisclosed transaction value. Asembia, headquartered in Florham Park, New Jersey, offers a comprehensive suite of services that includes patient support HUB services, specialty distribution, pharmacy software, and group purchasing solutions. This acquisition aligns with Peak Rock's investment strategy focused on high-growth, founder-owned healthcare businesses.

Asembia has established itself as a key player in the specialty pharma sector, facilitating access to therapies for patients, prescribers, and pharmaceutical manufacturers. The company also hosts the Asembia Specialty Pharmacy Summit, the largest national conference for specialty pharmacy, which draws thousands of industry professionals annually. This platform not only enhances Asembia's visibility within the industry but also underscores its commitment to fostering collaboration and innovation among stakeholders in the healthcare ecosystem.

The strategic rationale behind Peak Rock's acquisition centers on enhancing Asembia's technological capabilities and expanding its service offerings. Peak Rock aims to leverage its expertise in supporting transformational growth to bolster Asembia's existing operations, thereby improving patient experiences and outcomes. The investment will facilitate further advancements in technology and marketing initiatives, positioning Asembia to better serve its diverse clientele, which includes patients, pharmacies, and pharmaceutical manufacturers.

The healthcare sector, particularly the specialty pharmaceuticals market, has been experiencing significant growth due to increasing demand for specialized treatments and personalized medicine. As healthcare providers and pharmaceutical companies continue to seek innovative solutions to improve patient care, Asembia's comprehensive service model is well-positioned to capitalize on these trends. The partnership with Peak Rock Capital is expected to accelerate Asembia's growth trajectory, enabling it to pursue complementary acquisitions that will enhance its market position.

In conclusion, the acquisition of Asembia by Peak Rock Capital reflects broader trends within the healthcare industry, where technology-enabled solutions are increasingly vital for addressing complex patient needs. As the specialty pharma landscape evolves, this transaction highlights the ongoing commitment of private investment firms to support resilient healthcare businesses with strong growth potential. The collaboration is anticipated to yield significant benefits for all stakeholders involved, ultimately contributing to improved patient care and access to therapies.